Ibritumomab Intravenous and Lithium Citrate Syrup
Determining the interaction of Ibritumomab Intravenous and Lithium Citrate Syrup and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab, Ibritumomab Tiuxetan
Generic Name: lithium
Brand name: Lithobid, Eskalith, Lithonate, Lithotabs, Eskalith-CR
Synonyms: Lithium
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ibritumomab Intravenous-Lithium Controlled-Release and Extended-Release Tablets
- Ibritumomab Intravenous-Lithium ER
- Ibritumomab Intravenous-Lithium Oral Solution
- Ibritumomab Intravenous-Lithium Salts
- Ibritumomab Intravenous-Lithium Syrup and Oral Solution
- Ibritumomab Intravenous-Lithobid
- Lithium Citrate Syrup-Ibritumomab Tiuxetan
- Lithium Citrate Syrup-Ibrutinib
- Lithium Citrate Syrup-Ibrutinib Capsules
- Lithium Citrate Syrup-Ibrutinib Tablets
- Lithium Citrate Syrup-Ibu
- Lithium Citrate Syrup-IBU Tablets